New draft guidance from the Food and Drug Administration lays out steps the regulatory agency wants medical device manufacturers to address to reduce cybersecurity risks to the devices.

The FDA cites a growing concern to the safety of medical devices, yet regulators themselves are under fire after Arxan Technologies, a vendor of anti-tamper protection software, in a study found that 84 percent of mHealth apps tested did not adequately address at least two of the Open Web Application Security Project Mobile Top 10 Risks, Health Data Management recently reported.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access